Agios Pharmaceuticals AGIO Inventories
Inventories at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InventoryNet.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's inventories.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Agios Pharmaceuticals's inventories?
- Agios Pharmaceuticals (AGIO) reported inventories of $35.09M in Q1 2026.
- How has Agios Pharmaceuticals's inventories changed year-over-year?
- Agios Pharmaceuticals's inventories increased by 18.5% year-over-year, from $29.61M to $35.09M.
- What is the long-term trend for Agios Pharmaceuticals's inventories?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's inventories has grown at a 17.5% compound annual growth rate (CAGR), from $14.7M to $32.92M.
- What does inventories mean?
- Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.